TGFB1 and osteoarthritis: The authors suggested that TGF-β induces the activation of the SREBP-2 pathway through integrin subunit α V and PI3K, thus playing a key role in osteoarthritis, and that integrin blockage may be a potential molecular target for osteoarthritis therapy [30].